Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2025)

Camp4 Therapeutics' Other Non-Current Liabilities history spans 3 years, with the latest figure at $29000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $29000.0; the TTM value through Dec 2025 reached $29000.0, changed N/A, while the annual FY2025 figure was $29000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $29000.0 at Camp4 Therapeutics, down from $16.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $16.7 million in Q3 2025 and bottomed at $2000.0 in Q4 2023.
  • The 3-year median for Other Non-Current Liabilities is $2000.0 (2023), against an average of $2.8 million.
  • The largest YoY upside for Other Non-Current Liabilities was 836500.0% in 2025 against a maximum downside of 836500.0% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then soared by 1350.0% to $29000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Other Non-Current Liabilities are $29000.0 (Q4 2025), $16.7 million (Q3 2025), and $2000.0 (Q2 2025).